Drug shortages can have serious consequences for patients, including: ▪️ Delayed or disrupted care ▪️ Increased costs ▪️ Unexpected side effects when using alternative treatments Learn more: bit.ly/3QY0art

Today, GAP spotlights another steering committee member: Patients Rising. @patientsrising trains patients and caregivers to bring their real struggles into Congress, state legislatures, and regulatory agencies — and turn them into policy. Learn more: bit.ly/4bTvy4G

‼️STARTING NOW‼️ Tune into GAP's webinar, “Engaging FDA's User Fee Process" now, to hear from experts about getting involved in the FDA user fee reauthorization process to ensure timely patient access to prescription and generic medicines. 🔗 Join NOW: bit.ly/473b6vX

Join GAP and @patientaccess' webinar, "Engaging in FDA's User Fee Process" on September 21 to learn how patient advocates can get involved in the FDA user fee reauthorization process to ensure patient access to generic medicines. ‼️ Register now‼️ bit.ly/4rhh9X8

📢 Upcoming Webinar: Engaging in the FDA’s User Fee Process The upcoming GDUFA reauthorization offers advocates an important opportunity to help shape the FDA’s user fee programs. Register to learn about the process and how to make your voice heard: bit.ly/473b6vX

The Generic Drug User Fee Amendments help the @FDA expand access to effective and affordable generic medicines. With GDUFA IV’s 2027 renewal approaching, organizations can advocate for continued patient access. Learn more about how to get involved today: bit.ly/4r7U5tY

The Generics Access Project advocates for policies that promote #generic competition and efficient approval of generic medicines. Visit GAP’s website to learn more: genericsproject.org/

GAP’s survey found that patients overwhelmingly recognize the value #generics bring to patients and the health care system. Read the survey report: bit.ly/3QnhCFN

This week's GAP steering committee spotlight is the Global Colon Cancer Association. Their mission is to advocate for equitable access to quality colorectal cancer screenings, testing, treatments, and care. Learn more about @GlobalCRC: bit.ly/43lZcML

The Generics Access Project has 4 main priorities, all aimed at advocating for policies that promote generic competition and efficient approval of generic medicines. Learn more: bit.ly/3TLm3yW

Generic drugs are a critical part of the US health care system. But even as patients readily take generic medications, what is their level of trust in generics’ efficacy, safety and manufacturing? Read GAP's survey report to find out: bit.ly/3QnhCFN